MYNZ Mainz Biomed
- 4.830
- +0.180+3.87%
- 4.830
- 0.0000.00%
Mainz Biomed News
Mainz Biomed B.V. Addresses Nasdaq Listing Compliance Issue
Mainz Biomed | 6-K: Report of foreign private issuer (related to financial reporting)
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Quest Diagnostics Deal Sends Mainz Higher
Express News | Mainz Biomed NV - Quest to Provide Lab Services for Mainz Biomed's Reconaasense Study
Mainz Biomed Forms Agreement With Quest Diagnostics to Provide Clinical Trials Laboratory Services for Colorectal Cancer Screening Test
Mainz Biomed NV Trading Halted, Volatility Trading Pause
Mainz Biomed Announces Closing of $8.0 Million Follow-On Offering
Mainz Biomed Offering Expected to Close on or About December 16 >MYNZ
Mainz Biomed: Warrants Will Be Immediately Exercisable at $5.85 Per Share >MYNZ
Mainz Biomed: Each Unit Is Being Sold at $5.85 Apiece >MYNZ
Mainz Biomed Offering 1,367,521 Units, Each Consisting of One Share, One Series a Warrant, One Series B Warrant >MYNZ
Mainz Biomed: Maxim Group LLC Acting as Sole Placement Agent >MYNZ
Mainz Biomed Announces Pricing of $8.0 Million Follow-On Offering Priced At-the-Market
Mainz Biomed N.V. Announces Pricing of Follow-On Offering to Raise Approximately $8.0 Million
Express News | Mainz Biomed NV - Effective Offering Price $5.85 per Unit
Express News | Mainz Biomed Announces Pricing of $8.0 Million Follow-on Offering Priced at-the-Market Under Nasdaq Rules
Mainz Biomed Announces Pricing of $8.0 Million Follow-On Offering Priced At-the-Market Under Nasdaq Rules
Express News | Trading Halt: Halt Status Updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times
Mainz Biomed NV Trading Halted, News Pending
No Data